New Researchs at ACC26 on Everyday Clinical Decisions – The Lancet Group
The Lancet Group shared a post on LinkedIn:
“Cardiologists – The Lancet is at ACC26 with new research exploring everyday clinical decisions.
1.Aspirin vs clopidogrel after PCI:
Longest randomised follow-up (ten years) suggests sustained reductions in clinical events with clopidogrel compared with aspirin after PCI:
- Lower ischemic events with clopidogrel
- Lower bleeding events with clopidogrel
- No difference in mortality
‘These findings suggest that clopidogrel may be considered as the preferred agent for long-term antiplatelet monotherapy during the chronic maintenance phase after PCI’, say authors.
2.PCI before TAVI—necessary?
In patients with CAD, deferring PCI was noninferior to a PCI-first strategy at 1 year for death, MI, stroke, and major bleeding.
‘These findings support an initial conservative approach, although patient-tailored treatment strategies remain essential’, say authors.”
Title: Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial
Authors: Jeehoon Kang, Sungjoon Park, Han-Mo Yang, Eun-Seok Shin, Seung-Woon Rha, Jang-Whan Bae, Nam Ho Lee, Hyuck-Jun Yoon, Yoon Haeng Cho, Ung Kim, Song-Yi Kim, Sang-Hyun Kim, Jung-Kyu Han, Kyung Woo Park, Hyo-Soo Kim
Read the Full Article on The Lancet
Title: Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial
Authors: Ronak Delewi, Hugo M Aarts, Gijs M Broeze, Kimberley I Hemelrijk, Dirk Jan van Ginkel, Geert A A Versteeg, Maik J Grundeken, Bimmer E P M Claessen, Pim A L Tonino, Carl E Schotborgh, Martijn Meuwissen, Gert K van Houwelingen, Joanna J Wykrzykowska, Giovanni Amoroso, Tessel N Vossenberg, Pieter A Vriesendorp, Niels van Royen, Jurriën M ten Berg, Jan G P Tijssen, Michiel Voskuil
Read the Full Article on The Lancet
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 31, 2026, 12:58Akshat Jain: Invisible Blood – The Hidden Battle with Von Willebrand Disease
-
Mar 31, 2026, 12:50Emmanuele Kouvousis: DOAC Dose Adjustments for Older Patients
-
Mar 31, 2026, 12:34How Clinicians Prioritize Factors in Red Blood Cell Transfusions While Following Guidelines – AABB
-
Mar 31, 2026, 12:13Tareq Abadl: What if a Hospital Bacterium Can Survive on Dry Surfaces for Days to Weeks?
-
Mar 31, 2026, 11:35Lale Tokgözoğlu: Significant CV Benefit of Lowering LDL to 44 mg/dL in Diabetes
-
Mar 31, 2026, 09:08Shamee Shastry: Sharing Perspectives on Therapeutic Apheresis at AIIMS CME
-
Mar 31, 2026, 08:57Heghine Khachatryan: Heavy Menstrual Bleeding is Not ‘Normal’ – It is Often Missed Pathology
-
Mar 30, 2026, 18:24Tayyab Ibrahim: How the ‘Milli-Spinner’ is Changing Blood Clot Treatment
-
Mar 30, 2026, 17:49Peter Antevy: The Blood Type in the Cooler Shouldn’t Decide Whether She Lives